Origin of testicular germ cell neoplasia: The role of sex chromosomes

The Y Chromosome and Male Germ Cell Biology in Health and Diseases

Volumn , Issue , 2007, Pages 289-308

  Rajpert De Meyts, Ewa ^a   Ottesen, Anne Marie ^a   Hoei Hansen, Christina ^a   Sonne, Si Brask ^a   Leffers, Henrik ^a   Skakkebæk, Niels E ^a  

^a Rigshospitalet   (Denmark)

Author keywords

Carcinoma in situ testis; Dysgenesis; Germ cell tumor; Testicular; Testicular neoplasms; X chromosome; Y chromosome

Indexed keywords

EID: 40349107308     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1142/9789812770431_0014     Document Type: Chapter

References (112)

1. Adami, H., Bergström, R., Möhner, M., Zatonski, W., Storm, H., Ekbom, A., Tretli, S., Teppo, L., Ziegler, H., Rahu, M., et al. (1994). Testicular cancer in nine northern European countries. Int J Cancer 59, 33-38.
2. Aksglæde, L., Wikström, A. M., Rajpert-De Meyts, E., Dunkel, L., Skakkebæk, N. E., and Juul, A. (2006). Natural history of seminiferous tubule degeneration in Klinefelter syndrome. Hum Reprod Update 12, 39-48.
3. Almstrup, K., Hoei-Hansen, C. E., Wirkner, U., Blake, J., Schwager, C., Ansorge, W., Nielsen, J. E., Skakkebæk, N. E., Rajpert-DeMeyts, E., and Leffers, H. (2004). Embryonic stem cell-like features of testicular carcinoma in situ revealed by genome-wide gene expression profiling. Cancer Res 64, 4736-4743.
4. Aubry, F., Satie, A.-P., Rioux-Leclercq, N., Rajpert-De Meyts, E., Spagnoli, G. C., Chomez, P., De Backer, O., Jegou, B., and Samson, M. (2001). MAGE-A4, a germ-cell specific marker, is expressed differentially in testicular tumors. Cancer 92, 2778-2785.
5. Bianchi, N. O., Richard, S. M., and Pavicic, M. S. (2006). Y chromosome instability in testicular cancer. Mutat Res 612, 172-178.
6. Bianchi, N. O., Richard, S. M., Peltomäki, P., and Bianchi, M. S. (2002). Mosaic AZF deletions and susceptibility to testicular tumors. Mutat Res 503, 51-62.
7. Boisen, K. A., Main, K. M., Rajpert-De Meyts, E., and Skakkebæk, N. E. (2001). Are male reproductive disorders a common entity? The testicular dysgenesis syndrome. Ann N Y Acad Sci 948, 90-99.
8. Clark, A. T., Rodriguez, R. T., Bodnar, M. S., Abeyta, M. J., Cedars, M. I., Turek, P. J., Firpo, M. T., and Reijo Pera, R. A. (2004). Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells 22, 169-179.
9. Clemmesen, J. (1968). A doubling of morbidity from testis carcinoma in Copenhagen, 1943-1962. Acta Pathol Microbiol Scand 72, 348-349.
10. Coerdt,W., Rehder, H., Gausmann, I., Johannisson, R., and Gropp, A. (1985). Quantitative histology of human fetal testes in chromosomal disease. Pediatr Pathol 3, 245-259.
11. De Palma, A., Burrello, N., Barone, N., D’Agata, R., Vicari, E., and Calogero, A. E. (2005). Patientswith abnormal spermparameters have an increased sex chromosome aneuploidy rate in peripheral leukocytes. Hum Reprod 20, 2153-2156.
12. Fernandes, S., Huellen, K., Goncalves, J., Dukal, H., Zeisler, J., Rajpert-De Meyts, E., Skakkebæk, N. E., Habermann, B.,Krause,W., Sousa, M., et al. (2002). High frequency of DAZ1/DAZ2 gene deletions in patientswith severe oligozoospermia. MolHumReprod 8, 286-298.
13. Frydelund-Larsen, L., Vogt, P., Leffers, H., Schadwinkel, A., Daugaard, G., Skakkebæk, N. E., and Rajpert-De Meyts, E. (2003). No AZF deletion in 160 patients with testicular germ cell cancer. Mol Hum Reprod 9, 517-521.
14. Giglio, S., Pirola, B., Arrigo, G., Dagrada, P., Bardoni, B., Bernardi, F., Russo, G., Argentiero, L., Forabosco, A., Carrozzo, R., and Zuffardi, O. (2000). Opposite deletions/duplications of the X chromosome: two novel reciprocal rearrangements. Eur J Hum Genet 8, 63-70.
15. Hart, A. H., Hartley, L., Parker, K., Ibrahim, M., Looijenga, L. H., Pauchnik, M., Chow, C.W., and Robb, L. (2005). The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 104, 2092-2098.
16. Hildenbrand, R., Schroder, W., Brude, E., Schepler, A., Konig, R., Stutte, H. J., and Arnemann, J. (1999).Detection ofTSPYprotein in a unilateralmicroscopic gonadoblastoma of a Turner mosaic patient with a Y-derived marker chromosome. J Pathol 189, 623-626.
17. Hoei-Hansen, C. E.,Almstrup, K.,Nielsen, J. E., Brask, S. S.,Graem, N., Skakkebæk, N. E., Leffers, H., and Rajpert-DeMeyts, E. (2005). Stem cell pluripotency factor NANOG is expressed in human fetal gonocytes, testicular carcinoma in situ and germ cell tumours. Histopathology 47, 48-56.
18. Hoei-Hansen, C. E., Holm, M., Rajpert-De Meyts, E., and Skakkebæk, N. E. (2003). Histological evidence of testicular dysgenesis in contralateral biopsies of 218 patients with testicular germ cell cancer. J Pathol 200, 370-374.
19. Hoei-Hansen, C. E., Nielsen, J. E., Almstrup, K., Brask, S. S., Graem, N., Skakkebæk, N. E., Leffers, H., and Rajpert-De Meyts, E. (2004). Transcription factor AP-2γ is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors. Clin Cancer Res 10, 8521-8530.
20. Hoei-Hansen, C. E., Sehested, A., Juhler, M., Lau, Y. F., Skakkebæk, N. E., Laursen, H., and Rajpert-De Meyts, E. (2006). New evidence for the origin of intracranial germ cell tumors from primordial germ cells: expression of pluripotency and cell differentiation markers. J Pathol 209, 25-33.
21. Honecker, F., Stoop, H., de Krijger, R. R., Lau, Y.-F. C., Bokemeyer, C., and Looijenga, L. H. (2004). Pathobiological implications of the expression of markers of testicular carcinoma in situ by fetal germ cells. J Pathol 203, 849-857.
22. Huyghe, E., Matsuda, T., and Thonneau, P. (2003). Increasing incidence of testicular cancer worldwide: a review. J Urol 170, 5-11.
23. Jacobs, P. A., and Strong, J. A. (1959). A case of human intersexuality having a possible XXY sex-determining mechanism. Nature 183, 302-303.
24. Jobling, M. A., and Tyler-Smith, C. (2003). The human Y chromosome: an evolutionary marker comes of age. Nat Rev Genet 4, 598-612.
25. Jones, T. D., Ulbright, T. M., Eble, J. N., and Cheng, L. (2004). OCT4: a sensitive and specific biomarker for intratubular germ cell neoplasia of the testis. Clin Cancer Res 10, 8544-8547.
26. Jørgensen, N., Müller, J., Jaubert, F., Clausen, O. P., and Skakkebæk, N. E. (1997). Heterogeneity of gonadoblastoma germ cells: similarities with immature germ cells, spermatogonia and testicular carcinoma in situ cells. Histopathology 30, 177-186.
27. Jørgensen, N.,Rajpert-DeMeyts, E., Graem, N., Müller, J.,Giwercman, A., and Skakkebæk, N. E. (1995). Expression of immunohistochemical markers for testicular carcinoma in situ by normal human fetal germ cells. Lab Invest 72, 223-231.
28. Jungbluth, A. A., Busam, K. J., Kolb, D., Iversen, K., Coplan, K., Chen, Y. T., Spagnoli, G.C., and Old, L. J. (2000). Expression ofMAGE-antigens in normal tissues and cancer. Int J Cancer 85, 460-465.
29. Kawakami, T., Okamoto, K., Sugihara, H., Hattori, T., Reeve, A. E., Ogawa, O., and Okada, Y. (2003). The roles of supernumerical X chromosomes and XIST expression in testicular germ cell tumors. J Urol 169, 1546-1552.
30. Kersemaekers, A. M., Honecker, F., Stoop, H., Cools, M., Molier, M., Wolffenbuttel, K., Bokemeyer, C., Li, Y., Lau, Y. F., Oosterhuis, J. W., and Looijenga, L. H. J. (2005). Identification of germ cells at risk for neoplastic transformation in gonadoblastoma: an immunohistochemical study for OCT3/4 and TSPY. Hum Pathol 36, 512-521.
31. Klinefelter, H. F., Reifenstein, E. C., and Albright, F. (1942). Syndrome characterized by gynecomastia, aspermatogenesis without a-Leydigism, and increased excretion of follicle-stimulating hormone. J Clin Endocrinol 2, 615-627.
32. Koul, S., Houldsworth, J., Mansukhani,M.M., Donadio, A.,McKiernan, J. M.,Reuter,V. E., Bosl, G. J., Chaganti, R. S., and Murty, V. V. (2002). Characteristic promoter hypermethylation signatures in male germ cell tumors. Mol Cancer 1, 8 (online publication).
33. Krausz, C., Quintana-Murci, L., and Forti, G. (2004). Y chromosome polymorphisms in medicine. Ann Med 36, 573-583.
34. Krausz,C. G.,Quintana-Murci, L.,Rajpert-DeMeyts, E., Jørgensen, N., Jobling, M.,Rosser, Z. H., Skakkebæk, N. E., andMcElreavey,K. (2001a). Identification of aYchromosome haplogroup associated with reduced sperm counts. Hum Mol Genet 10, 1873-1877.
35. Krausz, C. G., Rajpert-De Meyts, E., Frydelund-Larsen, L., Quintana-Murci, L., McElreavey, K., and Skakkebæk, N. E. (2001b). Double-blind Y chromosome microdeletion analysis in men with known sperm parameters and reproductive hormone profiles. J Clin Endocrinol Metab 86, 2638-2642.
36. Kuroda-Kawaguchi, T., Skaletsky, H., Brown, L. G., Minx, P. J., Cordum, H. S.,Waterston, R. H., Wilson, R. K., Silber, S., Oates, R., Rozen, S., and Page, D. C. (2001). The AZFc region of the Y chromosome features massive palindromes and uniform recurrent deletions in infertile men. Nat Genet 29, 279-286.
37. Kuroki, Y., Iwamoto, T., Lee, J., Yoshiike, M., Nozawa, S., Nishida, T., Ewis, A. A., Nakamura, H., Toda, T., Tokunaga, K., et al. (1999). Spermatogenic ability is different among males in different Y chromosome lineage. J Hum Genet 44, 289-292.
38. Lau, Y. F., Chou, P. M., Iezzoni, J. C., Alonzo, J. A., and Kömüves, L.G. (2000). Expression of a candidate gene for the gonadoblastoma locus in gonadoblastoma and testicular seminoma. Cytogenet Cell Genet 91, 160-164.
39. Lau, Y. F., Lau, H.W., and Kömüves, L. G. (2003). Expression pattern of a gonadoblastoma candidate gene suggests a role of the Y chromosome in prostate cancer. Cytogenet Genome Res 101, 250-260.
40. Looijenga, L. H. J., Gillis, A. J. M., van Gurp, R. J. H. L. M., Verkerk, A. J. M. H., and Oosterhuis, J. W. (1997). X inactivation in human testicular tumors. XIST expression and androgen receptor methylation status. Am J Pathol 151, 581-590.
41. Looijenga, L. H. J., Stoop, H., de Leeuw, P. J. C., de Gouveia Brazao, C. A., Gillis, A. J. M., van Roozendaal, K. E., van Zoelen, E. J., Weber, R. F., Wolffenbuttel, K. P., van Dekken, H., et al. (2003). POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63, 2244-2250.
42. Lutke Holzik, M. F., Storm, K., Sijmons, R. H., D’Hollander, M., Arts, E. G., Verstraaten, M. L., Sleijfer, D. T., and Hoekstra, H. J. (2005). Absence of constitutional Y chromosome AZF deletions in patients with testicular germ cell tumors. Urology 65, 196-201.
43. Maio, M., Coral, S., Fratta, E., Altomonte, M., and Sigalotti, L. (2003). Epigenetic targets for immune intervention in human malignancies. Oncogene 22, 6484-6488.
44. McElreavey, K., Ravel, C., Chantot-Bastaraud, S., and Siffroi, J. P. (2006). Y chromosome variants and male reproductive function. Int J Androl 29, 298-303.
45. McKiernan, J. M., Goluboff, E. T., Liberson, G. L.,Golden, R., and Fisch, H. (1999). Rising risk of testicular cancer by birth cohort in the United States from 1973 to 1995. J Urol 162, 361-363.
46. Møller, H., and Skakkebæk, N. E. (1999). Risk of testicular cancer in subfertile men: casecontrol study. Br Med J 318, 559-562.
47. Müller, J., and Skakkebæk, N. E. (1984). Testicular carcinoma in situ in children with androgen insensitivity (testicular feminisation) syndrome. Br Med J 288, 1419-1420.
48. Müller, J., Skakkebæk, N. E.,Ritzén, E. M., Plöen, L., and Petersen, K. E. (1985).Carcinoma in situ of the testis in children with 45,X/46,XY gonadal dysgenesis. J Pediatr 106, 431-436.
49. Müller, J., Visfeldt, J., Philip, J., and Skakkebæk, N. E. (1992). Carcinoma in situ, gonadoblastoma, and early invasive neoplasia in a nine-year-old girl with 46,XYgonadal dysgenesis. APMIS 100, 170-174.
50. Nathanson, K. L., Kanetsky, P. A., Hawes, R., Vaughn, D. J., Letrero, R., Tucker, K., Friedlander, M., Phillips, K. A., Hogg, D., Jewett, M. A., et al. (2005). The Y deletion gr/gr and susceptibility to testicular germ cell tumor. Am J Hum Genet 77, 1034-1043.
51. Okada, Y., Nishikawa, R., Matsutani, M., and Louis, D. N. (2002). Hypomethylated X chromosome gain and rare isochromosome 12p in diverse intracranial germ cell tumors. J Neuropathol Exp Neurol 61, 531-538.
52. Page, D. C. (1987). Hypothesis: a Y-chromosomal gene causes gonadoblastoma in dysgenetic gonads. Development 101(Suppl), 151-155.
53. Papadimas, J., Goulis, D. G., Giannouli, C., Papanicolau, A., Tarlatzis, B., and Bontis, J. N. (2001). Ambiguous genitalia, 45,XY/46,XY mosaic karyotype, and Y chromosome microdeletions in a 17-year-old man. Fertil Steril 76, 1261-1263.
54. Papanikolaou, A. D., Goulis, D. G., Giannouli, C., Gounioti, C., Bontis, J. N., and Papadimas, J. (2003). Intratubular germ cell neoplasia in a man with ambiguous genitalia, 45,X/46,XYmosaic karyotype, andYchromosome microdeletions. Endocr Pathol 14, 177-182.
55. Pauls, K., Jager,R.,Weber, S.,Wardelmann,E.,Koch, A.,Buttner,R., and Schorle,H. (2005). Transcription factor AP-2 gamma, a novelmarker of gonocytes and seminomatous germ cell tumours. Int J Cancer 115, 470-477.
56. Peltomäki, P., Halme, A., and de la Chapelle, A. (1989). Molecular studies of the sex chromosomes in human testicular cancer: pronounced changes in X and Y chromosome dosage in some tumors. Genes Chromosomes Cancer 1, 42-47.
57. Peltomäki, P., Lothe, R., Borresen, A. L., Fosså, S. D., Brogger, A., and de la Chapelle, A. (1991). Altered dosage of the sex chromosomes in human testicular cancer: a molecular genetic study. Int J Cancer 47, 518-522.
58. Plath, K., Mlynarczyk-Evans, S., Nusinov, D. A., and Panning, B. (2002). Xist RNA and the mechanism of X chromosome inactivation. Annu Rev Genet 36, 233-278.
59. Purdue, M. P., Devesa, S. S., Sigurdson, A. J., and McGlynn, K. A. (2005). International patterns and trends in testis cancer incidence. Int J Cancer 115, 822-827.
60. Quintana-Murci, L., Weale, M. E., Thomas, M. G., Erdei, E., Bradman, N., Shanks, J. H., Krausz, C. G., and McElreavey, K. (2003). Y-chromosome haplotypes and testicular cancer in the English population. J Med Genet 40, e20.
61. Rajpert-De Meyts, E. (2006). Developmental model for the pathogenesis of testicular carcinoma in situ: genetic and environmental aspects. Hum Reprod Update 12, 303-323.
62. Rajpert-De Meyts, E., Bartkova, J., Samson, M., Hoei-Hansen, C. E., Frydelund-Larsen, L., Bartek, J., and Skakkebæk, N. E. (2003a). The emerging phenotype of the testicular carcinoma in situ germ cell. APMIS 111, 267-279.
63. Rajpert-De Meyts, E., Hanstein, R., Jorgensen, N., Graem, N., Vogt, P. H., and Skakkebæk, N. E. (2004). Developmental expression of POU5F1 (OCT-3/4) in normal and dysgenetic human gonads. Hum Reprod 19, 1338-1344.
64. Rajpert-De Meyts, E., Jacobsen, G. K., Bartkova, J., Aubry, F., Samson, M., Bartek, J., and Skakkebæk, N. E. (2003b). The immunohistochemical expression pattern of Chk2, p19INK4d, p53, MAGE-A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma. Histopathology 42, 1-10.
65. Rajpert-DeMeyts,E., Jørgensen, N.,Brøndum-Nielsen, K., Müller, J., and Skakkebæk,N.E. (1998). Developmental arrest of germ cells in the pathogenesis of germ cell neoplasia. APMIS 106, 198-206.
66. Rajpert-De Meyts, E., and Skakkebæk, N. E. (1994). Expression of the c-kit protein product in carcinoma in situ and invasive germ cell tumours. Int J Androl 17, 85-92.
67. Rajpert-De Meyts, E., and Skakkebæk, N. E. (2001). Biology of testicular carcinoma in situ, the stem-cell like precursor of germ cell cancer. In: Andrology in the 21st Century, B. Robaire, H. Chemes, & C. R. Morales, eds., Medimond, New York, pp. 409-417.
68. Rapley, E. A., Crockford, G. P., Teare, D., Biggs, P., Seal, S., Barfoot, R., Edwards, S., Hamoudi, R., Heimdal, K., Fosså, S. D., et al. (2000). Localization to Xq27 of a susceptibility gene for testicular germ-cell tumours. Nat Genet 24, 197-200.
69. Reijo, R., Lee, T. Y., Salo, P., Alagappan, R., Brown, L. G., Rosenberg, M., Rozen, S., Jaffe, T., Straus, D.,Hovatta, O., et al. (1995). Diverse spermatogenic defects in humans caused by Y chromosome deletions encompassing a novel RNA-binding protein gene. Nat Genet 10, 383-393.
70. Repping, S., Skaletsky, H., Brown, L., van Daalen, S. K., Korver, C. M., Pyntikova, T., Kuroda-Kawaguchi, T., de Vries, J. W., Oates, R. D., Silber, S., et al. (2003). Polymorphism for a 1.6-Mb deletion of the human Y chromosome persists through balance between recurrent mutation and haploid selection. Nat Genet 35, 247-251.
71. Repping, S., Skaletsky, H., Lange, J., Silber, S., van der Veen, F., Oates, R. D., Page, D. C., and Rozen, S. (2002). Recombination between palindromes P5 and P1 on the human Y chromosome causes massive deletions and spermatogenic failure. Am J Hum Genet 71, 906-922.
72. Repping, S., van Daalen, S. K.,Korver, C. M., Brown, L., Marszalek, J.,Gianotten, J.,Oates, R. D., Silber, S., van der Veen, F., Page, D. C., and Rozen, S. (2004). A family of human Y chromosomes has dispersed throughout northern Eurasia despite a 1.8-Mb deletion in the AZFc region. Genomics 83, 1046-1052.
73. Richard, S. M., Bianchi, N. O., Bianchi, M. S., Peltomäki, P., Lothe, R. A., and Pavicic,W. (2004). Ethnic variation in the prevalence of AZF deletions in testicular cancer. Mutat Res 554, 45-51.
74. Richiardi, L., Bellocco, R., Adami, H. O., Torrang, A., Barlow, L., Hakulinen, T., Rahu,M., Stengrevics, A., Storm, H., Tretli, S., et al. (2004). Testicular cancer incidence in eight northern European countries: secular and recent trends. Cancer Epidemiol Biomarkers Prev 13, 2157-2166.
75. Ross, M. T., Grafham, D. V., Coffey, A. J., Scherer, S., McLay, K., Muzny, D., Platzer, M., Howell, G. R., Burrows, C., Bird, C. P., et al. (2005). The DNA sequence of the human X chromosome. Nature 434, 325-337.
76. Salo, P., Kaariainen, H., Petrovic,V., Peltomaki, P., Page, D.C., and de laChapelle,A. (1995). Molecular mapping of the putative gonadoblastoma locus on the Y chromosome. Genes Chromosomes Cancer 14, 210-214.
77. Satie, A.-P., Rajpert-De Meyts, E., Spagnoli, G. C., Henno, S., Olivo, L., Jacobsen, G. K., Rioux-Leclercq, N., Jegou, B., and Samson, M. (2002). The cancer-testis gene, NY-ESO-1, is expressed in normal fetal and adult testes and in spermatocytic seminoma and testicular carcinoma in situ. Lab Invest 82, 775-780.
78. Savage, M. O., and Lowe, D. G. (1990). Gonadal neoplasia and abnormal sexual differentiation. Clin Endocrinol 32, 519-533.
79. Scanlan,M. J., Gure,A.O., Jungbluth, A. A.,Old, L. J., and Chen,Y. T. (2002). Cancer/testis antigens: an expanding family of targets for cancer immunotherapy. Immunol Rev 188, 22-32.
80. Schellhas, H. F. (1974). Malignant potential of the dysgenetic gonad. Obstet Gynecol 44, 298-309.
81. Schnieders, F., Dörk, T., Arnemann, J., Vogel, T., Werner, M., and Schmidtke, J. (1996). Testis-specific protein, Y-encoded (TSPY) expression in testicular tissues. Hum Mol Genet 5, 1801-1807.
82. Scully, R. E. (1970). Gonadoblastoma. A review of 74 cases. Cancer 25, 1340-1356.
83. Scully,R.E. (1981).Neoplasia associated with anomalous sexual development and abnormal sex chromosomes. Pediatr Adolesc Endocrinol 8, 203-217.
84. Siffroi, J. P., Le Bourhis, C., Krausz, C., Barbaux, S., Quintana-Murci, L., Kanafani, S., Rouba, H., Bujan, L., Bourrouillou, G., Seifer, I., et al. (2000). Sex chromosome mosaicism in males carrying Y chromosome long arm deletions. Hum Reprod 15, 2559-2562.
85. Skakkebæk, N. E. (1972). Possible carcinoma-in-situ of the testis. Lancet 2, 516-517.
86. Skakkebæk, N. E. (1975). Atypical germ cells in the adjacent ʼnormal’ tissue of testicular tumours. APMIS 83, 127-130.
87. Skakkebæk, N. E. (1978). Carcinoma in situ of the testis: frequency and relationship to invasive germ cell tumours in infertile men. Histopathology 2, 157-170.
88. Skakkebæk, N. E., Berthelsen, J. G., Giwercman, A., and Müller, J. (1987). Carcinoma-insitu of the testis: possible origin from gonocytes and precursor of all types of germ cell tumours except spermatocytoma. Int J Androl 10, 19-28.
89. Skakkebæk, N. E., Rajpert-De Meyts, E., Jørgensen, N., Carlsen, E., Petersen, P. M., Giwercman, A., Andersen, A. G., Jensen, T. K., Andersson, A.-M., and Müller, J. (1998). Germ cell cancer and disorders of spermatogenesis: an environmental connection?. APMIS 106, 3-12.
90. Skakkebæk, N. E., Rajpert-De Meyts, E., and Main, K. M. (2001). Testicular dysgenesis syndrome: an increasingly commondevelopmental disorder with environmental aspects. Hum Reprod 16, 972-978.
91. Skaletsky, H., Kuroda-Kawaguchi, T., Minx, P., Cordum, H., Hillier, L., Brown, L., Repping, S., Pyntikova, T., Ali, J., Bieri, T., et al. (2003). The male-specific region of the human Y chromosome is a mosaic of discrete sequence classes. Nature 423, 825-837.
92. Slowikowska-Hilczer, J., Romer, T. E., and Kula, K. (2003). Neoplastic potential of germ cells in relation to disturbances of gonadal organogenesis and changes in karyotype. J Androl 24, 270-278.
93. Small, K., Iber, J., and Warren, S. T. (1997). Emerin deletion reveals a common X-chromosome inversion mediated by inverted repeats. Nat Genet 16, 96-99.
94. Smiraglia, D. J., Szymanska, J., Kraggerud, S. M., Lothe, R. A., Peltomaki, P., and Plass, C. (2002). Distinct epigenetic phenotypes in seminomatous and nonseminomatous testicular germ cell tumors. Oncogene 21, 3909-3916.
95. Sohval, A. R. (1956). Testicular dysgenesis in relation to neoplasm of the testicle. J Urol 75, 285-291.
96. Spatz, A., Borg, C., and Feunteun, J. (2004). X-chromosome genetics and human cancer. Nat Rev Cancer 4, 617-629.
97. Sperger, J.M., Chen, X., Draper, J. S., Antosiewicz, J. E., Chon, C. H., Jones, S. B., Brooks, J. D., Andrews, P. W., Brown, P. O., and Thomson, J. A. (2003). Gene expression patterns in human embryonic stem cells and human pluripotent germ cell tumors. Proc Natl Acad Sci U S A 100, 13350-13355.
98. Stoop, H., Honecker, F., Cools, M., de Krijger, R., Bokemeyer, C., and Looijenga, L. H. (2005). Differentiation and development of human female germ cells during prenatal gonadogenesis: an immunohistochemical study. Hum Reprod 20, 1466-1476.
99. Teter, J., Philip, J., andWecewicz, G. (1964). ‘Mixed’ gonadal dysgenesis with gonadoblastoma in situ. Am J Obstet Gynecol 90, 929-935.
100. Tiepolo, L., and Zuffardi, O. (1976). Localization of factors controlling spermatogenesis in the nonfluorescent portion of the human Y chromosome long arm. Hum Genet 34, 119-124.
101. Toppari, J., Larsen, J. C., Christiansen, P.,Giwercman, A., Grandjean, P., Guillette, L. J., Jr., Jégou,B., Jensen, T. K., Jouannet, P.,Keiding, N., et al. (1996).Male reproductive health and environmental xenoestrogens. Environ Health Perspect. 104(Suppl 4), 741-803.
102. Troche, V., and Hernandez, E. (1986). Neoplasia arising in dysgenetic gonads. Obstet Gynecol Surv 41, 74-79.
103. Tsuchiya, K.,Reijo,R., Page, D.C., and Disteche,C. M. (1995).Gonadoblastoma: molecular definition of the susceptibility region on the Y chromosome. Am J Hum Genet 57, 1400-1407.
104. Ulbright, T.M.,Amin,M. B., and Young, R.H. (1999). Atlas of Tumor Pathology: Tumors of the Testis, Adnexa, Spermatic Cord, and Scrotum, Armed Forces Institute of Pathology, Washington, DC, pp. 1-385.
105. Vogt, P. H. (2005). AZF deletions and Y chromosomal haplogroups: history and update based on sequence. Hum Reprod Update 4, 319-336.
106. Vogt, P. H., Chandley, A. C., Hargreave, T. B., Keil, R., Ma, K., and Sharkey, A. (1992). Microdeletions in interval 6 of the Y chromosome of males with idiopathic sterility points to disruption of AZF, a human spermatogenesis gene. Hum Genet 89, 491-496.
107. Wang, P. J. (2004). X chromosomes, retrogenes and their role in male reproduction. Trends Endocrinol Metab 15, 79-83.
108. Wang, P. J., McCarrey, J. R., Yang, F., and Page, D. C. (2001). An abundance of X-linked genes expressed in spermatogonia. Nat Genet 27, 422-426.
109. Warburton, P. E., Giordano, J., Cheung, F., Gelfand, Y., and Benson, G. (2004). Inverted repeat structure of the human genome: the X-chromosome contains a preponderance of large, highly homologous inverted repeats that contain testes genes. Genome Res 14, 1861-1869.
110. Weir,H.K., Marrett,L. D.,Kreiger,N., Darlington, G. A., and Sugar,L. (2000). Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer. Int J Cancer 87, 438-443.
111. Yuasa, T., Okamoto, K., Kawakami, T., Mishina, M., Ogawa, O., and Okada, Y. (2001). Expression patterns of cancer testis antigens in testicular germ cell tumors and adjacent testicular tissue. J Urol 165, 1790-1794.
112. Zendman, A. J., Zschocke, J., van Kraats, A. A., de Wit, N. J., Kurpisz, M., Weidle, U. H., Ruiter, D. J.,Weiss, E. H., and vanMuijen, G. N. (2003). The human SPANXmultigene family: genomic organization, alignment and expression in male germ cells and tumor cell lines. Gene 309, 125-133.